Fire and rescue personnel work in the area where a medical rescue helicopter crashed, Monday, Aug. 28, 2023, in Pompano Beach, Fla. (AP Photo/Marta Lavandier)
By Terry Spencer
A medical rescue helicopter caught fire and broke apart shortly after takeoff Monday before crashing into an apartment complex near Fort Lauderdale, killing a paramedic captain on board and a resident on the ground, authorities said.
Two others on board and two other people at the apartment complex were injured.
Broward County Fire-Rescue Capt. Terryson Jackson, 49, and a woman died when the Broward Sheriff's Office helicopter crashed through the complex's roof after taking off from Pompano Beach Airpark at about 8:45 a.m., Sheriff Gregory Tony said. He said the four injured were taken to the hospital and are expected to survive.
Jackson was a 19-year veteran of the department.
“Terryson was a rock star, he was one of the best of us,” said Tony, who also oversees the county's fire department. “He bled this profession inside and out all day long.”
The injured firefighters are pilot Daron Roche, 37, and Mike Chaguaceda, 31.
The dead woman's name was not released as her family was being notified, Tony said.
The three-member crew was heading to an emergency medical rescue to take the patient to the hospital. A video posted online shows flames coming from the midsection of the helicopter as it is trailed by a long plume of smoke. The helicopter then appears to break in half as it begins to spiral, plunging to the ground. A video from another angle showed that the helicopter's blades were not turning rapidly.
Tony said that even as the crew members were declaring a mayday to the airport's control tower and trying to save their helicopter, they were also radioing paramedics at the medical emergency to let them know they would have to take the patient to the hospital.
“We are talking about the character of these men,” Tony said. “As they were fighting for their lives, they were thinking about somebody else.”
Witness Brian Piggott told the South Florida Sun Sentinel that the helicopter began trailing smoke as soon as it took off. It then lost altitude and crashed.
Victoria Walczak, who was inside the apartment building, said the crash was louder than thunder.
“I thought a bomb went off,” she told the newspaper.
The National Transportation Safety Board is investigating the crash.
Healthcare workforce management platform ShiftMed
recently announced a $45 million funding round.
The company's platform connects nurses and healthcare professionals to hospitals and other healthcare providers.
ShiftMed's new funding comes amid widespread labor shortages in the healthcare sector. The company's CEO Todd Walrath joins Cheddar News' Closing Bell to discuss.
Universities like UCLA, Yale, and Duke have announced they're implementing remote learning amid the COVID omicron variant surge, despite President Biden recommending that K-12 schools should continue in-person education. Jared C. Bass, senior director for Higher Education at American Progress, joined Cheddar to break down what institutions of higher education might be considering differently. "I think some universities are allowing periods of a bit of a respite to allow students to get testing and make sure when they do return back to campus that they're healthy," he noted.
Supply chain issues have become one of the biggest roadblocks for the U.S. EV market, with production woes likely to stunt the industry's growth in 2022. Rich Steinberg, electric vehicle expert and industry advisor, told Cheddar that the Biden administration investing in domestic mining for essential minerals used in battery manufacturing — such as lithium — could help alleviate the bottlenecks. "Some of those same materials are available domestically, they just haven't been prioritized," he said, noting the paradox between green tech and "dirty" mining. "The good news is that there are ways to extract those materials cleanly."
Hyperfine, the pioneer of the very first FDA-approved portable MRI device, made its public debut on the Nasdaq via a SPAC merger. CEO Dave Scott joined Cheddar's "Opening Bell" to discuss the IPO launch, the company's valuation at $580 million, and the impact of its machine called Swoop. "We can roll an MRI system, our MRI Swoop system, right into the room where you are, right up to your patient bedside, and scan you right there and get an image in less than an hour," he explained.
Dr. Rob Davidson, Executive Director of the Committee to Protect Health Care and an ER Physician in West Michigan, joins Cheddar News to break down the expectations of Pfizer's new COVID-19 treatment pill.
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
